SS/JrHsdMcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
9 |
146.0 |
um |
5.4 |
16.2 |
ex vivo videomicroscopy |
0.0 |
0 |
|
67244 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
157.0 |
um |
2.0 |
4.9 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69573 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
133.0 |
um |
3.4 |
8.33 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69582 |
732 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
10 days-12 days |
4 |
111.0 |
um |
6.0 |
12.0 |
ex vivo method |
0.0 |
0 |
resting diameter |
100750 |
2520 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
156.0 |
um |
3.9 |
10.32 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69558 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
0.9% sodium chloride solution (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
155.0 |
um |
8.6 |
21.07 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69570 |
732 |
SD-Nfe2l2em1Mcwi+/+ |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
4 |
126.0 |
um |
12.1 |
24.2 |
ex vivo method |
0.0 |
0 |
resting diameter |
100753 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then angiotensin II (100 ng/kg/min) (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
5 |
136.0 |
um |
10.2 |
22.81 |
ex vivo method |
0.0 |
0 |
resting diameter |
100754 |
2520 |
SS.BN-(D13Rat124-D13Rat101)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
154.0 |
um |
6.6 |
14.76 |
ex vivo videomicroscopy |
0.0 |
0 |
|
68117 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
148.0 |
um |
3.7 |
9.06 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69579 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
10 |
145.0 |
um |
3.5 |
11.07 |
ex vivo videomicroscopy |
0.0 |
0 |
|
68111 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
147.0 |
um |
2.3 |
6.09 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69567 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
angiotensin II (3 ng/kg/min) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
5 |
113.0 |
um |
4.2 |
9.39 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69576 |
732 |
SD-Nfe2l2em1Mcwi+/+ |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
5 |
145.0 |
um |
12.5 |
27.95 |
ex vivo method |
0.0 |
0 |
resting diameter |
100751 |
2520 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled captopril content drinking water (100 mg/kg/d) (for 3 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
145.0 |
um |
8.4 |
20.58 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69561 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
7 |
131.0 |
um |
5.7 |
15.08 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69555 |
732 |
SS/JrHsdMcwi |
middle cerebral artery inner diameter |
controlled tempol content drinking water (15 mg/kg/d) (for 3 days) then physiological salt solution perfusate then NG-nitroarginine methyl ester (100 umol/l) (for 0.3 hours) |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
138.0 |
um |
10.1 |
24.74 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69585 |
732 |
SD-Nfe2l2em1Mcwi+/+ |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
10 days-12 days |
4 |
129.0 |
um |
9.6 |
19.2 |
ex vivo method |
0.0 |
0 |
resting diameter |
100749 |
2520 |
SD-Nfe2l2em1Mcwi-/- |
middle cerebral artery inner diameter |
controlled sodium content diet (0.4 %) (between 70 and 84 days) then controlled sodium content diet (4 %) (for 6 days) then vehicle control condition (for 3 days) then physiological salt solution perfusate |
Priestley JR, et al., Am J Physiol Heart Circ Physiol. 2016 Feb 15;310(4):H478-87. doi: 10.1152/ajpheart.00586.2015. Epub 2015 Dec 4. |
cerebral artery size trait |
male |
9 days-11 days |
4 |
154.0 |
um |
15.0 |
30.0 |
ex vivo method |
0.0 |
0 |
resting diameter |
100752 |
2520 |
SS.BN-(D13Rat77-D13Rat105)/Mcwi |
middle cerebral artery inner diameter |
physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
6 |
148.0 |
um |
4.4 |
10.78 |
ex vivo videomicroscopy |
0.0 |
0 |
|
68114 |
732 |
SS.BN-(D13Hmgc41-D13Hmgc23)/Mcwi |
middle cerebral artery inner diameter |
controlled losartan content drinking water (20 mg/kg/d) (for 7 days) then physiological salt solution perfusate |
Durand MJ, et al., Am J Physiol Heart Circ Physiol. 2010 Dec;299(6):H1865-74. Epub 2010 Sep 17. |
cerebral artery size trait |
male |
63 days-98 days |
8 |
152.0 |
um |
6.1 |
17.25 |
ex vivo videomicroscopy |
0.0 |
0 |
|
69564 |
732 |